PRODUCT LITERATURE
Cisapride: A Novel Gastroprokinetic Drug
Impaired gastrointestinal motility underlies a multitude of digestive complaints. Metoclopramide, an antidopaminergic and cholinomimetic agen~ was the first prokinetic drug used to treat such conditions, but a high incidence of adverse effects has limited its use, especially in inf ants. Domperidone, the second prokinetic drug marketed in Canada, is a potent peripheral dopamine receptor antagonist which does not cross the blood-brain barrier well and, therefore, displays minimal CNS side effects. Cisapride is a gastroprokinetic agent which appears to act mainly by releasing acetylcholine from the myenteric plexus of the gut.
No other version available